Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents. https://t.co/UzjdMNM9Bw
RT @BIOTRONIK_US: #ICYMI: 2-year BIOFLOW-V results published in Sept. show significantly lower TLF, TV-MI & TLR events favoring ultrathin s…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT2018, review the 2-year data published in @JACCJournals: https://t.co/sFwjph2rjL #infographic #clinicaltrial #cardiotwitter #cathlab
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT2018, review the 2-year data published in @JACCJournals: https://t.co/sFwjph2rjL #infographic #clinicaltrial #cardiotwitter #cathlab
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
RT @BIOTRONIK_US: The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT20…
The BIOFLOW-V pivotal trial results showed excellent safety & efficacy for the #FDA-approved Orsiro DES. #ICYMI at #TCT2018, review the 2-year data published in @JACCJournals: https://t.co/sFwjph2rjL #infographic #clinicaltrial #cardiotwitter #cathlab
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
"The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer composition as key features for iterative DES development." @Kandzari | https://t.co/ggvM6gedVd @JACCJournals #JACCINT #ComplexPC
Excellent data in JACC! Exciting times! 2019 will be the year of #ultrathinstruts
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
"The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer composition as key features for iterative DES development." @Kandzari | https://t.co/ggvM6gedVd @JACCJournals #JACCINT #ComplexPC
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
"The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer composition as key features for iterative DES development." -@Kandzari @JACCJournals #JACCINT #ComplexPCI #cardiology #cardiotwit
RT @JACCJournals: New study in #JACC suggests bioresorbable sirolimus stent may outperform thin-strut everolimus stent: https://t.co/Ad7rf4…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
RT @BIOTRONIK_US: "The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer…
"The results not only advance a standard of comparison for new DES but also direct attention to strut thickness & polymer composition as key features for iterative DES development." @Kandzari | https://t.co/ggvM6gedVd @JACCJournals #JACCINT #ComplexPC
Are you implanting bioresorbable stents in your CAD patients? https://t.co/rPeMOkD22z #JACC @Kandzari
RT @JACCJournals: New study in #JACC suggests bioresorbable sirolimus stent may outperform thin-strut everolimus stent: https://t.co/Ad7rf4…
RT @JACCJournals: New study in #JACC suggests bioresorbable sirolimus stent may outperform thin-strut everolimus stent: https://t.co/Ad7rf4…
RT @sarahhudsonuk: Bioresorbable polymer better than durable polymer for stents, or is it simply that thinner struts are better? The BIOFL…
RT @sarahhudsonuk: Bioresorbable polymer better than durable polymer for stents, or is it simply that thinner struts are better? The BIOFL…
Bioresorbable polymer better than durable polymer for stents, or is it simply that thinner struts are better? The BIOFLOW V results are published in this weeks @JACCJournals https://t.co/9uWNKUDsUs #CardioEd https://t.co/Je0wSNIqPp
RT @JACCJournals: New study in #JACC suggests bioresorbable sirolimus stent may outperform thin-strut everolimus stent: https://t.co/Ad7rf4…
RT @JACCJournals: New study in #JACC suggests bioresorbable sirolimus stent may outperform thin-strut everolimus stent: https://t.co/Ad7rf4…
RT @JACCJournals: New study in #JACC suggests bioresorbable sirolimus stent may outperform thin-strut everolimus stent: https://t.co/Ad7rf4…
Bioflowに関しては このコメントが勉強になるのでは https://t.co/b9fLVCUj6A
RT @JACCJournals: New study in #JACC suggests bioresorbable sirolimus stent may outperform thin-strut everolimus stent: https://t.co/Ad7rf4…
RT @JACCJournals: New study in #JACC suggests bioresorbable sirolimus stent may outperform thin-strut everolimus stent: https://t.co/Ad7rf4…
New study in #JACC suggests bioresorbable sirolimus stent may outperform thin-strut everolimus stent: https://t.co/Ad7rf4Xqp9 @Kandzari https://t.co/XF2bUg0mKg
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents https://t.co/ctMR29fEza
RT @BIOTRONIK_US: #ICYMI: 2-year BIOFLOW-V results published in Sept. show significantly lower TLF, TV-MI & TLR events favoring ultrathin s…
RT @BIOTRONIK_US: #ICYMI: 2-year BIOFLOW-V results published in Sept. show significantly lower TLF, TV-MI & TLR events favoring ultrathin s…
RT @BIOTRONIK_US: #ICYMI: 2-year BIOFLOW-V results published in Sept. show significantly lower TLF, TV-MI & TLR events favoring ultrathin s…
#ICYMI: 2-year BIOFLOW-V results published in Sept. show significantly lower TLF, TV-MI & TLR events favoring ultrathin strut BP SES Orsiro vs. thin strut DP EES Xience. | @JACCJournals #JACC #JACCINT #TCT2018 #cardiotwitter #cardiology #PCI #ComplexP
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents: BIOFLOW V 2-Year Results. https://t.co/qRJK8e6fcy
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents: BIOFLOW V 2-Year Results. https://t.co/UzjdMO3L06
RT @BIOTRONIK_US: Two-year BIOFLOW-V results show significantly lower TLF, TV-MI and TLR events favoring ultrathin strut BP SES Orsiro vs.…
RT @BIOTRONIK_US: Two-year BIOFLOW-V results show significantly lower TLF, TV-MI and TLR events favoring ultrathin strut BP SES Orsiro vs.…
RT @BIOTRONIK_US: Two-year BIOFLOW-V results show significantly lower TLF, TV-MI and TLR events favoring ultrathin strut BP SES Orsiro vs.…
RT @BIOTRONIK_US: Two-year BIOFLOW-V results show significantly lower TLF, TV-MI and TLR events favoring ultrathin strut BP SES Orsiro vs.…
RT @BIOTRONIK_US: Two-year BIOFLOW-V results show significantly lower TLF, TV-MI and TLR events favoring ultrathin strut BP SES Orsiro vs.…
RT @BIOTRONIK_US: Two-year BIOFLOW-V results show significantly lower TLF, TV-MI and TLR events favoring ultrathin strut BP SES Orsiro vs.…
Two-year BIOFLOW-V results show significantly lower TLF, TV-MI and TLR events favoring ultrathin strut BP SES Orsiro vs. thin strut DP EES Xience. | @JACCJournals #JACC #JACCINT #TCT2018 #cardiotwitter #clinicaltrial #cardiology #PCI #ComplexPCI https://